[Use of carminomycin on children and adolescents with osteogenic sarcoma].
The therapeutic effect of carminomycin was studied in clinic at different treatment schemes with respect to 14 children and juvenile patients with osteogenic sarcoma. Pronounced local effect evident from disappearance of the pain and in some cases decrease of the metastatic tumor were noted in the patients with metastases of the osteogenic sarcoma to the bones or relapses of the primary tumor. Subjective improvement and objective effect were observed respectively in 90 and 53 per cent of the patients with metastases into the lungs and pronounced lung symptomatology.
D000293:Adolescent; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001132:Arm; D001859:Bone Neoplasms / Q000188:drug therapy*; D002360:Carubicin / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007866:Leg; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D002360:Carubicin
Primenenie karminomitsina u deteĭ i podrostkov s osteogennoĭ sarkomoĭ.